The Short Answer
Yes, some appetite suppressants work, but how well depends almost entirely on which type you mean. Prescription GLP1 medicines have produced average weight loss of roughly 11% to 20% in large trials lasting more than a year. Most supplements sold online have little reliable evidence behind them.
If you have ever stood in a pharmacy aisle wondering whether a bottle of capsules could really stop the evening snacking, you are not alone. This guide walks through what the research shows for each category, what the numbers mean in real life, and what the studies cannot tell you.
What Is an Appetite Suppressant?
An appetite suppressant is any product designed to reduce hunger or help you feel full sooner, so you eat less without relying purely on willpower. They work in a few different ways.
Some act on the hunger centres of the brain, raising chemicals such as noradrenaline that dampen the urge to eat. Others mimic gut hormones like GLP1, which your body releases after a meal to signal fullness and slow how quickly your stomach empties. Fibre supplements simply swell in the stomach and take up space.
The mechanism matters because it largely predicts the results. Products that copy the body’s own fullness signals have by far the strongest evidence.
Over the Counter Supplements: Mostly Weak Evidence
The supplements advertised on social media are the least proven category. Popular ingredients include green tea extract, garcinia cambogia, glucomannan, raspberry ketones and caffeine blends.
When independent researchers have tested these in controlled trials, the effects have generally been small, inconsistent or no better than a placebo. Glucomannan, a soluble fibre, has some of the better data, but even there the extra weight loss tends to be modest. Garcinia cambogia and raspberry ketones have not shown meaningful benefits in well designed human studies.
There is also a quality problem. Supplements are not tested like medicines before they reach the shelf, and regulators have repeatedly found products sold online that contain undeclared drugs. If a product promises dramatic results with no effort, treat that as a warning sign rather than a selling point.
Older Prescription Suppressants: Phentermine and Diethylpropion
Phentermine and diethylpropion are stimulant appetite suppressants that have been used for decades. They act on the brain to reduce hunger and are usually prescribed for short courses alongside diet and exercise.
Research shows they do work better than placebo. Trials and reviews generally report a few extra percent of body weight lost over several months compared with diet changes alone, with many people reaching around 5% of their starting weight. That is a real benefit, though smaller than what the newest medicines achieve.
Because they are stimulants, they can raise heart rate and blood pressure and may cause dry mouth, poor sleep or restlessness. They are not suitable for people with heart problems, uncontrolled high blood pressure or a history of anxiety. If you are looking into appetite suppressant tablets UK options in this category, a proper medical assessment beforehand is essential.
GLP1 Injections: The Strongest Evidence So Far
The biggest shift in weight management research has come from GLP1 based injections. Semaglutide (sold as Wegovy) and tirzepatide (sold as Mounjaro) mimic hormones that regulate appetite, so people tend to feel satisfied with smaller portions and think about food less often.
The trial numbers are striking. In the STEP 1 trial, adults on weekly semaglutide lost about 15% of their body weight on average over 68 weeks, compared with around 2% on placebo. In SURMOUNT 1, the highest dose of tirzepatide produced average weight loss of about 21% over 72 weeks. When the two were compared head to head, tirzepatide came out ahead, with 20.2% average weight loss against 13.7% for semaglutide.
These results are why Mounjaro and Wegovy injections are now widely used for adults with a BMI of 30 or above, or 27 and above with a weight related condition such as type 2 diabetes. The most common side effects are nausea, constipation and diarrhoea, which usually ease as the dose is increased gradually.
Daily GLP1 Tablets: The Wegovy Pill and Foundayo
For people who would rather avoid needles, 2026 brought two once daily GLP1 tablets to the UK. The Wegovy pill (oral semaglutide) was licensed in June, and Foundayo (orforglipron) was approved by the MHRA on 10 August 2026, making the UK the first country in Europe to license it.
In its main trial, the Wegovy pill produced average weight loss of 13.6%. In the ATTAIN 1 trial of more than 3,000 adults, the highest dose of orforglipron led to average weight loss of 11.2% over 72 weeks, compared with 2.1% on placebo. More than half of the people on that dose lost at least 10% of their body weight. You can read more about Foundayo weight loss results and what they mean in practice.
Foundayo can be taken at any time of day, with or without food, which some people find easier than the fasting rules attached to oral semaglutide. Daily Weight Loss Tablets suit people who want a simple routine without injections, while those aiming for the largest possible loss may still do better with an injection.
What the Research Does Not Tell You
Averages hide a wide range. In every trial, some people lose far more than the average and some lose very little. Your own response depends on your starting weight, genetics, other medicines, sleep, stress and how well you tolerate the treatment.
Stopping is another key issue. Studies consistently show that when people stop a GLP1 medicine, appetite tends to return and much of the lost weight can come back within a year. These medicines are increasingly seen as ongoing treatment for a chronic condition rather than a quick fix. Encouragingly, a trial of people who switched from injections to orforglipron found they kept most of the weight they had already lost.
Finally, none of these treatments replace the basics. Every major trial paired medication with a reduced calorie diet and more physical activity, and the results reflect that combination.
The Bottom Line
So, do appetite suppressants actually work? The evidence says it depends on the product. Most supplements offer little beyond hope, older stimulant medicines give modest results, and GLP1 injections and tablets have produced the largest, best documented weight loss of any medicines to date.
The safest route is a treatment chosen with a qualified clinician who reviews your full health history. Weight Medics can help you compare prescription options and decide whether medication is right for you, with proper clinical oversight from start to finish.
Frequently Asked Questions
Do natural appetite suppressants work?
Some fibre supplements may help you feel slightly fuller, but most natural products show small or inconsistent effects in research. They are not comparable to prescription medicines.
How much weight can you lose with an appetite suppressant?
It depends on the type. Stimulant medicines often lead to around 5% weight loss, daily GLP1 tablets around 11% to 14%, and GLP1 injections around 15% to 20% on average in trials lasting more than a year.
Are appetite suppressants safe?
Licensed medicines have been studied in large trials, but all have side effects and none suit everyone. A clinician should review your medical history before prescribing.
Will the weight come back if I stop?
Often, at least partly. Hunger usually returns after stopping, so it helps to plan for maintenance, whether that means continuing treatment, moving to a gentler option or strengthening your diet and activity habits.
Can I buy appetite suppressants without a prescription in the UK?
Only supplements. Medicines such as Wegovy, Mounjaro, Foundayo and phentermine need a prescription, and buying them from unregulated websites carries serious risks, including fake or contaminated products.
